Latest Breaking News On - European renal association dialysis - Page 2 : vimarsana.com

Our friend and our enemy : Rheumatologists continue to grapple with steroids

Our friend and our enemy : Rheumatologists continue to grapple with steroids
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUniversity of oklahomaHospital for special surgeryJoant merrillShenaz baghaByrob volanskyRichard furieUniversity of oklahoma health sciences centerNorthwell healthArthritis care researchAmerican college of rheumatologyArthritis clinical immunology programEuropean renal association dialysisOklahoma medical research foundationArthritis foundation

Equillium (EQ) Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis

Equillium (EQ) Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kenneth kalunianEquillium incEuropean renal associationPeuropean league against rheumatismBruce steelCalifornia san diego schoolEuropean renal association dialysisTransplant association

Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1

Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1 - read this article along with other careers information, tips and advice on BioSpace

United kingdomUnited statesFrance generalNoord hollandPushkal gargJaap groothoffUniversity of amsterdamDrug administrationAlnylam pharmaceuticals incExchange commissionAlnylam pharmaceuticalsInternational congressAmerican society of nephrologyHead of the department pediatric nephrologyEuropean medicines agencyEuropean renal association

Avacopan Shows Efficacy Signal for Rare Kidney Disease, C3G

Avacopan, recently FDA approved for ANCA-associated vasculitis, showed significant benefit for reducing disease chronicity in a randomized trial of 52 patients with C3 glomerulopathy.

New yorkUnited statesNorth carolinaAndrews bombackTejas desaiAchillion alexionColumbia university irving medical centerDrug administrationUs department of veterans affairsNational organization for rare diseasesEuropean renal associationWorld congressOffice of orphan products developmentEuropean renal association dialysisTransplant associationMedscape medical

Mayo Classification by US Useful for Rare Kidney Disease

The Mayo classification of autosomal dominant polycystic kidney disease based on ultrasound rather than MRI findings performs well, report clinicians from Spain.

Javier naranjoReuters healthPuerta del mar university hospitalEuropean renal associationClinical kidneyEuropean renal association dialysisTransplant associationWorking groupsInherited kidney disordersEuropean renal best practicePredicting renal outcomePolycystic kidney diseaseClinical kidney journalChronic renal failureHronic kidney failureHronic kidney disease ckd